Literature DB >> 11590220

Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines.

W Khovidhunkit1, A H Moser, J K Shigenaga, C Grunfeld, K R Feingold.   

Abstract

Multiple changes in HDL metabolism occur during infection and inflammation that could potentially impair the antiatherogenic functions of HDL. Scavenger receptor class B type I (SR-BI) promotes cholesterol efflux from peripheral cells and mediates selective uptake of cholesteryl ester into hepatocytes, thereby playing a pivotal role in reverse cholesterol transport. We studied the effect of endotoxin (lipopolysaccharide, LPS) and cytokines [tumor necrosis factor (TNF) and interleukin 1 (IL-1)] on hepatic SR-BI mRNA and protein levels in Syrian hamsters. LPS significantly decreased SR-BI mRNA levels in hamster liver. This effect was rapid and sustained, and was associated with a decrease in hepatic SR-BI protein levels. High cholesterol diet did not change hepatic SR-BI mRNA levels, and LPS was able to decrease SR-BI mRNA levels during high cholesterol feeding. TNF and IL-1 decreased SR-BI mRNA levels in the liver, and the effects of TNF and IL-1 were additive. TNF and IL-1 also decreased SR-BI levels in Hep3B hepatoma cells. More importantly, TNF and IL-1 decreased the uptake of HDL cholesteryl ester into Hep3B cells. In addition, we studied the effect of LPS on SR-BI mRNA in RAW 264.7 cells, a macrophage cell line. LPS rapidly decreased SR-BI mRNA levels in RAW 264.7 cells, but the effect was not sustained and did not lead to a reduction in SR-BI protein levels. Our results suggest that the decrease in hepatic SR-BI levels due to LPS and cytokines during infection and inflammation may decrease selective uptake of cholesteryl ester into the liver and result in impaired reverse cholesterol transport.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11590220

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  11 in total

1.  The acute phase response inhibits reverse cholesterol transport.

Authors:  Kenneth R Feingold; Carl Grunfeld
Journal:  J Lipid Res       Date:  2010-01-13       Impact factor: 5.922

2.  Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice.

Authors:  Ling Guo; Zhong Zheng; Junting Ai; Bin Huang; Xiang-An Li
Journal:  J Biol Chem       Date:  2014-04-09       Impact factor: 5.157

3.  The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I.

Authors:  Gunther Marsche; Sasa Frank; John G Raynes; Karen F Kozarsky; Wolfgang Sattler; Ernst Malle
Journal:  Biochem J       Date:  2007-02-15       Impact factor: 3.857

4.  Inflammation modulates human HDL composition and function in vivo.

Authors:  Margarita de la Llera Moya; Fiona C McGillicuddy; Christine C Hinkle; Michael Byrne; Michelle R Joshi; Vihn Nguyen; Jennifer Tabita-Martinez; Megan L Wolfe; Karen Badellino; Leticia Pruscino; Nehal N Mehta; Bela F Asztalos; Muredach P Reilly
Journal:  Atherosclerosis       Date:  2012-02-28       Impact factor: 5.162

5.  Autoimmune-mediated reduction of high-density lipoprotein-cholesterol and paraoxonase 1 activity in systemic lupus erythematosus-prone gld mice.

Authors:  Roshni Srivastava; Shaohua Yu; Brian W Parks; Leland L Black; Janusz H Kabarowski
Journal:  Arthritis Rheum       Date:  2011-01

6.  SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance.

Authors:  Lei Cai; Ailing Ji; Frederick C de Beer; Lisa R Tannock; Deneys R van der Westhuyzen
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

7.  Inflammation impairs reverse cholesterol transport in vivo.

Authors:  Fiona C McGillicuddy; Margarita de la Llera Moya; Christine C Hinkle; Michelle R Joshi; Elise H Chiquoine; Jeffrey T Billheimer; George H Rothblat; Muredach P Reilly
Journal:  Circulation       Date:  2009-02-16       Impact factor: 29.690

8.  MCP-1 impacts RCT by repressing ABCA1, ABCG1, and SR-BI through PI3K/Akt posttranslational regulation in HepG2 cells.

Authors:  Can-Xia Huang; Yu-Ling Zhang; Jing-Feng Wang; Jie-Yu Jiang; Jin-Lan Bao
Journal:  J Lipid Res       Date:  2013-02-12       Impact factor: 5.922

Review 9.  New insights into the emerging effects of inflammatory response on HDL particles structure and function.

Authors:  Xin Su; Guoming Zhang; Ye Cheng; Bin Wang
Journal:  Mol Biol Rep       Date:  2021-07-28       Impact factor: 2.316

10.  Scavenger receptors and their potential as therapeutic targets in the treatment of cardiovascular disease.

Authors:  Sam L Stephen; Katie Freestone; Sarah Dunn; Michael W Twigg; Shervanthi Homer-Vanniasinkam; John H Walker; Stephen B Wheatcroft; Sreenivasan Ponnambalam
Journal:  Int J Hypertens       Date:  2010-08-17       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.